Seeing Is Believing
with an average price target of $7.21. This is a potential upside of $5.16 (251.71%) from yesterday's end of day stock price of $2.05.
Leap Therapeutics's activity chart (see below) currently has 18 price targets and 33 ratings on display.
Analysts average stock forecasts to be materialized ratio is 40.74% with an average time for these price targets to be met of 338 days.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 27-Mar-2025. First documented stock forecast 07-Mar-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Mar-2025
1 years 8 days ago
(27-Mar-2025)
0/6 (0%)
$2.92 (113.18%)
Buy Since 03-Jun-2021
$9
$6.95 (339.02%)
2 years 16 days ago
(19-Mar-2024)
0/2 (0%)
$6.8 (309.09%)
Buy Since 17-May-2021
2 years 17 days ago
(18-Mar-2024)
1/3 (33.33%)
$28.9 (260.36%)
669
Buy Since 05-Oct-2021
2 years 4 months 15 days ago
(20-Nov-2023)
1/3 (33.33%)
$-23.1 (-79.38%)
382
Buy Since 05-Apr-2022
2 years 4 months 21 days ago
(14-Nov-2023)
0/2 (0%)
$13.21 (348.55%)
What is LPTX (Leap Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LPTX (Leap Therapeutics) with a proven track record?
Which analyst has the current lower performing score on LPTX (Leap Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LPTX (Leap Therapeutics)?
Which analyst is the currently most bullish on LPTX (Leap Therapeutics)?
Which analyst is the currently most reserved on LPTX (Leap Therapeutics)?